FDA Adds Transparency On Paragraph IVs In Bid To Spur Competition

 
• By Aidan Fry
  
Jellyfish
The FDA is offering greater transparency on pargraph IV patent challenges is a bid to spur greater generic competition • Source: Shutterstock

More from Generics

More from Products